eConsent
Ease of understanding for patients. Full visibility and automated control over the consent process for sponsors. Extend your clinical trial command and control center with Suvoda eConsent.
Patients
Only 53% of patients understand the potential for placebos in clinical research from informed consent documents i
Amendments
Protocols with 3+ amendments add 3 weeks to planned treatment duration, on average i
Visibility
Experience 100% visibility over consent and reconsent at all sites and for all patients
Improve patient comprehension. Reduce site burden. And decrease regulatory risk, delays, and expenses created by mid-trial consent requirements.
In today’s clinical studies for novel, life-changing therapeutics, informed consent isn’t just a first step in a patient’s trial journey. It is central to a patient’s understanding of study procedures and is a critical ethical requirement. And it is a process that must be repeated along the way, as the vast majority of protocol amendments require the patients to re-consent. The result is heightened risk of patient misunderstanding, regulatory non-compliance, heavier administrative burden, and increased study expense and duration.
When approximately 70% of the oncology studies we support have at least one protocol amendment, the patient experience and sponsor visibility of Suvoda eConsent make it a must-have tool for study and site teams—and their patients.
eConsent
Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated e-Consent
Trials conducted
with 75% in oncology, rare disease, and CNS
Countries supported
with trial sites in thousands of locations
Client satisfaction
year after year, in our annual company survey
Powerful features that drive patient understanding and reduce regulatory risk.
Suvoda eConsent features robust functionality that gives patients the tools they need to understand study information, which often includes complex medical and legal terms and concepts. At the same time, the visibility over consent across all study sites and patients means sponsors have control over the full process to minimize delays and reduce the risk of a regulatory finding.
Patient comprehension
-
Embedded videos and FAQs
-
In-document discussion threads
-
Cross-linked glossary
Flexible design
-
Electronic signature, wet ink upload, or print-and-sign consent
-
Can accommodate multiple consent types (subject, caregiver, legally authorized representative)
-
Can support multiple, separately timestamped signatures from a participant in a single consent form
-
Multilingual capability
-
Available on multiple devices—web-based, on-site, or patient device
Built on our single clinical trial technology platform, Suvoda eConsent and IRT drive automated control.
To your study and site users, eConsent will simply appear as additional functionality within the Suvoda IRT system. Why? So that data is seamlessly shared, workflows are fully streamlined, and the process is completely controlled. We’ll simply upload your approved consent documents, and whenever a site user begins a study visit, IRT will automatically check in with Suvoda eConsent to confirm that the patient has consented to the latest. If not, a prompt within the IRT drives completion of the consent forms—a matter of just a few clicks within the same digital environment—before the visit is allowed to proceed.
A simple user experience across eConsent and IRT applications - for simplified training and workflow.
Clients have consistently given Suvoda IRT high marks for its minimalist look and feel, intuitive navigation, and patient-centric processes—and ability to drive focus on the immediate task at hand.
Suvoda eConsent has the same intuitive user interface, managed in the same digital environment as IRT. It enables study and site professionals to calmly and smoothly move from randomization and trial supply management (RTSM) activities to eConsent tasks and back again, without needing to sign onto a new system or significant additional user training. And their ease with the system should help patients find the informed consent process more accessible and understandable.
Gain real-time visibility to subjects’ consent status across all your sites, right in the Suvoda IRT system.
We know that if you can’t measure it, you can’t manage it. That’s why Suvoda eConsent maximizes transparency and visibility, compiling critical consent data and presenting it through our robust IRT reporting tools.
Identify, in real-time, the sites that are lagging in getting patients to consent to the latest versions. Digitally archive consent documents for compliance and audit. With full access to eConsent reports, study teams and field monitors can then take early corrective actions with outlier sites and verify consents were done properly without the need for physical visits. The result? Increased regulatory compliance and reduced risk of excluded patients and discarded data at the end of the trial.
eConsent FAQs
Informed consent is a foundational requirement in clinical trials. Participants must clearly understand the study, its risks and benefits, and their rights before agreeing to participate.
Traditional paper consent forms can be long and difficult to navigate for patients. eConsent improves the process by presenting information in a clearer, more engaging way while creating a reliable digital record of consent.
eConsent is also important because it serves as a consent management solution, giving sites and sponsors real-time visibility into consent status and automated control across the trial. Rather than waiting on manual reporting or paper-based tracking, study teams can see at any moment who has consented, who is pending, and which version of the consent form each participant signed—supporting faster oversight and cleaner documentation.
eConsent is used by several stakeholders involved in running a clinical trial. Research sites use eConsent to present study information to participants, guide them through the consent process, and document consent electronically. Sponsors and CROs use eConsent to standardize consent workflows across studies, maintain oversight, and capture regulatory documentation properly. Participants use eConsent to review study information, ask questions, and provide informed consent using a digital device such as a tablet, computer, or smartphone.
Suvoda eConsent is part of the unified Suvoda Platform. This means the consent process can connect directly with other clinical trial workflows such as randomization, eCOA, patient payments, travel coordination, and study management.
Because these capabilities operate within the same platform, participant information and study events can flow across systems without relying on multiple disconnected tools. Study teams can manage consent, participant activities, and related workflows within a single ecosystem, reducing operational complexity for sites and improving visibility for sponsors.
The approach also helps support a more streamlined participant experience. They can review consent materials and continue managing other study activities within the same connected environment instead of navigating separate systems.
Powering the patient's digital journey in life-changing clinical trials
Broad perspective. Keen insight. Calm guidance.
Broad perspective. Keen insight. Calm guidance.
Seamless technology in complex ecosystems
Seamless technology in complex ecosystems
INSIGHTS & NEWS
-
BLOG
eConsent for clinical trials: Frequently Asked Questions (FAQ)
Jul 27, 2026 -
BLOG
Modernizing the clinical trial patient journey: Three ways technology can simplify the experience
Jul 23, 2026 -
BLOG
Financial barriers in clinical trials: what patient data tells us
Jul 9, 2026 -
ON-DEMAND
Reduce clinical trial site burden through better workflows
Jun 25, 2026 -
BLOG
Responsible AI in clinical trials starts with how it is designed
Jun 25, 2026 -
BLOG
Flexible by design: how Suvoda RTSM supports early-phase oncology trials
Jun 23, 2026 -
BLOG
Electronic Clinical Outcome Assessments (eCOA) in Clinical Trials
Jun 22, 2026 -
BLOG
What is Interactive Response Technology (IRT)?
Jun 19, 2026 -
BLOG
What is patient payments for clinical trials?
Jun 18, 2026 -
BLOG
How Suvoda RTSM automates adaptive enrollment in basket trials
Jun 12, 2026